SODIUM CHLORIDE, USP (GRANULAR) 2.5KG by Letco Medical Safety Data Sheet Section 1: Identification Common Name/Trade Name SODIUM CHLORIDE GRANULAR USP Supplier Information Letco Medical, LLC 1316 Commerce Drive NW Decatur, AL 35601 1 (800) 239-5288 +1 (734) 843-4693 IN CASE OF EMERGENCY: Chemtrec 1 (800) 424-9300 (24 hours) Product Synonym(s) N/A Relevant Use(s) of Product Manuf acture or Compounding of Substances Section 2: Hazards Identification Classification of Substance or Mixture Skin corrosion/irritation (Category 2), Serious eye damage/eye irritation (Category 2A) Signal Word Warning Hazard Statement(s) H315 Causes skin irritation H319 Causes serious eye irritation Pictogram(s) Precautionary Statement(s) P264 Wash hands thoroughly af ter handling. P280 Wear protective gloves/protective clothing/eye protection/f ace protection. P302+P352 IF ON SKIN Wash with soap and water. P305+P351+P338 IF IN EYES Rinse cautiously with water f or several minutes. Remove contact lenses if present and easy to do. continue rinsing. P332+P313 If skin irritation occurs Get medical advice/attention. P337+P313 If eye irritation persists Get medical advice/attention. Hazards Not Otherwise Classified No data available Ingredient(s) with Unknown Toxicity No data available Section 3: Composition/Information on Ingredients Chemical Name Sodium Chloride Common Name Sodium Chloride CAS Number 7647-14-5 Impurities and/or Stabilizing Additives No data available Section 4: First Aid Measures General Advice Remove from exposure. Remove contaminated clothing. For treatment advice, seek guidance from an occupational health physician or other licensed health-care provider f amiliar with workplace chemical exposures. In the United States, the national poison control center phone number is 1-800-222-1222. If person is not breathing, give artif icial respiration. If breathing is dif f icult, give oxygen if available. Persons developing serious hypersensitivity (anaphylactic) reactions must receive immediate medical attention. If Inhaled Move to fresh air. Call a physician if symptoms develop or persist. In Case of Skin Contact Remove contaminated clothing. Wash of f with soap and plenty of water. If skin irritation occurs: Get medical advice/attention. In Case of Eye Contact Rinse cautiously with water f or several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists. If Swallowed Call a POISON CENTER or doctor/physician if you f eel unwell. Rinse mouth. Most Important Symptoms and Effects Irritation of eyes and mucous membranes. Treatment of overdose should be symptomatic and supportive and may include the f ollowing: Dilute with 4 to 8 ounces of water or milk. For hypernatremia: Slowly administer intravenously a solution containing 30 to 50 mEq/liter of sodium (half as chloride and half as bicarbonate). For seizures: Administer a benzodiazepine IV. Consider phenobarbital if seizures recur. Monitor f or hypotension, dysrhythmias, respiratory depression, and need f or endotracheal intubation. Evaluate f or hypoglycemia, electrolyte disturbances, and hypoxia. For hypotension: Inf use 10 to 20 mL/kg isotonic f luid. If hypotension persists, administer dopamine or norepinephrine. For cerebral edema: Administer IV mannitol to remove excess intracellular water from the brain. Peritoneal and hemodialysis may be used to restore normal electrolyte levels. (Meditext) Provide general supportive measures and treat symptomatically. Page 1 of 5 Section 5: Fire Fighting Measures Suitable Extinguishing Media Water spray, dry chemical, carbon dioxide, or f oam as appropriate f or surrounding f ire and materials. Special Hazards Arising From the Substance/Mixture No unusual f ire explosion hazards noted. Special PPE and/or Precautions for Firefighters Wear suitable protective equipment. As with all f ires, evacuate personnel to a saf e area. Firef ighters should use selfcontained breathing equipment and protective clothing. Cool containers exposed to f lames with water until well af ter the f ire is out. Section 6: Accidental Release Measures Personal Precautions, Protective Equipment and Emergency Procedures Keep unnecessary personnel away. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Ensure adequate ventilation. Avoid inhalation of dust from the spilled material. Avoid inhalation of dust from the spilled material. Wear appropriate personal protective equipment. Methods and Materials Used for Containment Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of SDS. Wash spill site. Cleanup Procedures Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Wash spill site. Section 7: Handling and Storage Precautions for Safe Handling As a general rule, when handling chemicals, avoid all contact and inhalation of dust, mists, and/or vapors associated with the material. Clean equipment and work surf aces with suitable detergent or solvent af ter use. Af ter removing gloves, wash hands and other exposed skin thoroughly. Conditions for Safe Storage Store in tight container as def ined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity. Section 8: Exposure Controls/Personal Protection Components with Workplace Control Parameters No exposure standards allocated. Appropriate Engineering Controls Airborne exposures should be controlled primarily by engineering controls such as general dilution ventilation, local exhaust ventilation, or process enclosure. Local exhaust ventilation is generally pref erred to general exhaust because it can control the contaminant at its source, preventing dispersion into the work area. An industrial hygiene survey involving air monitoring may be used to determine the ef f ectiveness of engineering controls. Ef f ectiveness of engineering controls intended f or use with highly potent materials should be assessed by use of nontoxic surrogate materials. PPE - Eye/Face Protection Saf ety glasses with side shields are recommended. Face shields or goggles may be required if splash potential exists or if corrosive materials are present. Approved eye protection is pref erred. Maintain eyewash f acilities in the work area. PPE - Skin Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or other synthetic nonlatex gloves. Use of powdered latex gloves should be avoided due to the risk of latex allergy. PPE - Body Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or other synthetic nonlatex gloves. Use of powdered latex gloves should be avoided due to the risk of latex allergy. For handling of laboratory scale quantities, a cloth lab coat is recommended. Where signif icant quantities are handled, work clothing may be necessary to prevent take-home contamination. PPE - Respiratory Protection Where respirators are deemed necessary to reduce or control occupational exposures, use NIOSH-approved respiratory protection and have an ef f ective respirator program in place. Page 2 of 5 Section 9: Physical and Chemical Properties Appearance Form: Powder Physical state: Solid Colour: White crystals or crystalline powder. Upper/Lower Flammability or Explosive Limits No data available Odor Odourless Vapor Pressure 1 mm Hg @ 865 � C Odor Threshold No data available Vapor Density No data available pH 6.7 - 7.3 Relative Density No data available Melting Point/Freezing Point 1473.8 - 1479.2 �F (801 - 804 �C) Solubility Solubility in water Soluble: Slightly soluble in boiling water. Initial Boiling Point and Boiling Range 2575.4 �F (1413 �C) Flash Point No data available Evaporation Rate No data available Flammability (Solid, Gas) No data available Partition Coefficient No data available Auto-Ignition Temperature No data available Decomposition Temperature No data available Viscosity No data available Section 10: Stability and Reactivity Reactivity No reactivity hazards known. Chemical Stability Material is stable under normal conditions. Possibility of Hazardous Reactions No dangerous reaction known under conditions of normal use. Conditions to Avoid No data available Incompatible Materials Lithium, bromine trif luoride, and strong oxidizing agents. Hazardous Decomposition Products Irritating and/or toxic f umes or gases. Emits toxic f umes under f ire conditions. NaOx. Cl-. Page 3 of 5 Section 11: Toxicological Information Acute Toxicity - LD50 Oral Oral LD50 Mouse 4000 mg/kg Rat 3000 mg/kg Other LD50 Mouse 2602 mg/kg Acute Toxicity - Inhalation Based on available data, the classif ication criteria are not met. Acute Toxicity - Dermal No data available Acute Toxicity - Eye Causes serious eye irritation. Skin Corrosion/Irritation Causes skin irritation. Serious Eye Damage/Irritation Causes serious eye irritation. Respiratory or Skin Sensitazation Due to lack of data the classif ication is not possible. Germ Cell Mutagenicity Sodium chloride produced DNA damage in mammalian assays employing mouse lymphocytes, induced unscheduled DNA synthesis in rats, and caused DNA damage in hamster ovaries. Tests in Saccharomyces cerevisia and Escherichia coli were also positive. However, the overall importance of these f indings is questionable because these studies used very high sodium levels that would tend to disrupt the cellular osmotic balance and DNA microenvironment, especially in the in vitro studies. [EPA 2003] Based on available data, the classif ication criteria are not met. Carcinogenicity IARC This product is not considered to be a carcinogen by IARC. Carcinogenicity ACGIH This product is not considered to be carcinogen by ACGIH. Carcinogenicity NTP This product is not considered to be carcinogen by NTP. Carcinogenicity OSHA This product in not considered to be carcinogen by OSHA. Reproductive Toxicity No adverse development ef f ects of excessive sodium chloride intake or injection have been reported in human pregnancies, but it may worsen gestational high blood pressure. Based on available data, the classif ication criteria are not met. Specific Target Organ Toxicity - Single Exposure Due to lack of data the classif ication is not possible. Specific Target Organ Toxicity - Repeated Exposure Due to lack of data the classif ication is not possible. Aspiration Hazard Based on available data, the classif ication criteria are not met. Section 12: Ecological Information Toxicity Ecotoxicity Product Sodium Chloride (CAS 7647-14-5) Aquatic Crustacea EC50 Water f lea (Daphnia magna) 340.7 - 469.2 mg/l, 48 hours Fish LC50 American eel (Anguilla rostrata) 0 - 27260 mg/l, 96 hours Persistence and Degradability No data available Bio-accumulative Potential No data available Mobility in Soil No data available Other Adverse Effects No data available Section 13: Disposal Considerations Waste Treatment Methods Product This product, in its present state, when discarded or disposed of , its not a hazardous waste according to Federal regulations (40 CFR 261.4 (b) 94). Under RCRA, its it the responsibility of the user or the product to determine, at the time of disposal, whether the product meets RCRA criteria f or hazardous waste. Dispose of contents/container in accordance with local/regional/international regulations. Waste Treatment Methods Packaging Empty containers or liners may retain some product residues. This material and its container must be disposed of in a saf e manner (see Disposal instructions). Special Precautions Landfill or Incinerations Empty containers should be taken to an approved waste handling site f or recycling or disposal. Since emptied containers may retain product residue, f ollow label warnings even af ter container is emptied. Other Information No data available Section 14: Transport Information UN Number Not dangerous goods. UN Proper Shipping Name N/A Transport Hazard Class(es) N/A Packaging Group N/A Environmental Hazards N/A Section 15: Regulatory Information CERCLA/SARA Hazardous Substances - Not applicable. All components are on the U.S EPA TSCA Inventory List. Superf und Amendments and Reauthorization Act of 1986 (SARA) Hazard categories Immediate Hazard - No Delayed Hazard - No Fire Hazard - No Pressure Hazard- No Reactivity Hazard- No SARA 302 Extremely hazardous substance: No SARA 311/312 Hazardous chemical: No Other f ederal regulations Saf e Drinking Water Act (SDWA) Not regulated Food and Drug Administration (FDA) Not regulated US state regulations Calif ornia Saf e Drinking Water and Toxic Enf orcement Act of 1986 (Proposition 65): This material is not known to contain any chemicals currently listed as carcinogens or reproductive toxins. Issue Date 01/19/2007 Revision Date 01/16/2013. Page 4 of 5 Section 16: Other Information Additional Information Prepared By Lisa Russell Revision Date 01/09/2019 16:38 Disclaimer Letco Medical, LLC believes that the above information is correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. If the product is used as a component in another product, this information may not be applicable. NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE INFORMATION PROVIDED ABOVE. Letco Medical shall not be held liable for any loss or damage resulting from handling, storage, use or from contact with the above product. Page 5 of 5
